Clare Ventures provides the capital female-founded businesses deserve to innovate, scale and create lasting impact.
OUR MISSION
Clare Ventures has an insatiable appetite to close the gender funding gap that sees female founders unfairly disadvantaged when it comes to receiving the investment they need to thrive.
Only 3%-5% of VC funding globally goes to all-female teams.
Male founders receive on average 5.9x the amount of early-stage VC funding as female founders.
In New Zealand, startups founded by women are shut out of all but 7 in every 100 investment opportunities.
With 95 percent of venture capital dollars being controlled by men, the presence of women across the investment spectrum is slim.
Gender Reporting for Fund I
Lifetime of Portfolio up to 31/12/24
Gender of founding teams of our portfolio companies
By percentage of deals closed
All Women Teams
64.7Mixed Teams(35.3%)
By percentage of capital invested
All Women Teams
36.4Mixed Teams(63.6%)
All Women*
Mixed Team**
All Men
* We define women to include all women identifying, regardless of the gender they were assigned at birth.
** Mixed Team includes men, women, and non-binary founders.
OUR PORTFOLIO
Sharesies exists to make investing easy and accessible. Before, investing was too hard, too complex, and too damned scary for too many. Deciding to build an accessible digital investment platform was a no-brainer. Sharesies’ investing experience works towards giving people the confidence and control to invest, with the belief that by giving someone the opportunity to invest—while supporting them to learn— they can create a community of financially empowered people.
Orbis Diagnostics is a next-generation point of care diagnostics company that is transforming personal healthcare. Powered by microfluidic and photonic innovations, Orbis’ automated desktop system has miniaturised medical labs to deliver real-time, actionable test results from a finger-prick of blood. Orbis is developing a comprehensive portfolio of diagnostic solutions that will improve health outcomes by making routine blood testing more convenient and accessible.
Founded after a traumatic birth experience, and inspired to prove to the world we can do better, Baymatob uses AI-guided solutions to improve health outcomes for mothers and their babies. Oli PPH, Baymatob’s AI-guided maternity sensor, a monitoring and diagnostic platform, empowers healthcare providers to acquire, interpret and predict critical information on pregnancy progression and risks to mothers and their babies. Oli PPH is aiming to save lives and reduce the occurrence of preventable maternal death around the world.
The world’s most popular recipe organiser, revolutionising the way home cooks organise, plan and shop for their recipes. Originating in Australia in late 2022, the app was founded by a trio of passionate home-cooks, with the app allowing for recipes on social sites, websites and blogs, printed out or recipes that grandma has written down for you to be easily imported and organised.
LATEST NEWS
Baymatob’s Oli procures $6.5m to monitor the leading cause of preventable maternal death
The Sydney-based company is now involved in U.S. clinical trials, as well as trials at the Royal North Shore and Royal Hospital for Women in Sydney for their Oli device which was awarded a ‘Breakthrough Device Designation’ by the FDA, in 2021.
Clare Ventures is Aotearoa’s leading growth-stage venture capital fund. Founded, funded, and focused entirely by and for women.
